SPANSULES PHAMATECH PVT LTD

Type: Manufacturer (Factory)

Company Introduction:

SPANSULES PHARMATECH PVT LTD is an Indian pharmaceutical company primarily engaged in the manufacturing of high-quality pharmaceutical formulations. Based in India, the company specializes in the development and production of a wide range of dosage forms, including various types of pellets, granules, and finished pharmaceutical products.

As a dedicated manufacturer, SPANSULES PHARMATECH operates its own production facilities, adhering to stringent international quality standards and regulatory guidelines. The company is committed to providing contract manufacturing services and formulation development expertise, serving both domestic and global pharmaceutical markets. Their operations are characterized by a strong focus on research and development, quality assurance, and a commitment to delivering innovative and effective pharmaceutical solutions.

The company SPANSULES PHAMATECH PVT LTD from India primarily manufactures and sells a range of pharmaceutical products and offers related services.

Their core product offerings include:

Pharmaceutical Pellets: They specialize in the production of various types of pharmaceutical pellets, which serve as intermediaries for different dosage forms. These include API coated pellets for drugs such as Omeprazole, Lansoprazole, Rabeprazole, Esomeprazole, Duloxetine, Venlafaxine, and Itraconazole. They also produce sustained release pellets, delayed release pellets, taste masked pellets, and nutraceutical pellets. These multi-particulate systems are designed for controlled drug delivery.

Finished Dosage Forms: Utilizing their pellet technology, Spansules Pharmatech also manufactures finished pharmaceutical products. This primarily includes capsules filled with their specialized pellets. They may also produce tablets incorporating their pellet formulations.

Contract Manufacturing and Development Services: Beyond their own product line, the company provides contract development and manufacturing organization (CDMO) services to other pharmaceutical companies. These services encompass product development, analytical services, scale-up, and commercial manufacturing of pharmaceutical products, often leveraging their expertise in pelletization technology.